Beta Bionics (BBNX) Total Liabilities (2023 - 2026)

Beta Bionics has disclosed Total Liabilities across 4 years of filings, most recently posting $33.2 million for Q1 2026.

• Total Liabilities for Q1 2026 came in at $33.2 million, up 36.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $33.2 million (up 36.67% YoY), and the FY2025 annual result was $41.1 million, down 44.14% from the prior year.
• Total Liabilities came in at $33.2 million for Q1 2026 at Beta Bionics, down from $41.1 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $228.8 million in Q3 2024 to a low of $24.3 million in Q1 2025.
• The 4-year median for Total Liabilities is $46.3 million (2023), against an average of $95.2 million.
• Across the five-year window, Total Liabilities surged 43.16% in 2024 and sank 88.68% in 2025, its largest moves.
• Beta Bionics' Total Liabilities stood at $51.4 million in 2023, then soared by 43.16% to $73.6 million in 2024, then tumbled by 44.14% to $41.1 million in 2025, then dropped by 19.35% to $33.2 million in 2026.
• The last three Total Liabilities figures came in at $33.2 million (Q1 2026), $41.1 million (Q4 2025), and $35.3 million (Q3 2025), per Business Quant data.